A detailed history of Congress Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Congress Wealth Management LLC holds 189,969 shares of BMY stock, worth $11.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
189,969
Previous 63,618 198.61%
Holding current value
$11.1 Million
Previous $2.64 Million 272.07%
% of portfolio
0.14%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $5.01 Million - $6.54 Million
126,351 Added 198.61%
189,969 $9.83 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $2.08 Million - $2.74 Million
51,698 Added 433.71%
63,618 $2.64 Million
Q1 2024

Apr 18, 2024

SELL
$47.98 - $54.4 $414,163 - $469,580
-8,632 Reduced 42.0%
11,920 $646,000
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $523,147 - $624,259
10,791 Added 110.55%
20,552 $1.05 Million
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $54,474 - $60,910
-941 Reduced 8.79%
9,761 $566,000
Q2 2023

Jul 13, 2023

SELL
$63.71 - $70.74 $100,598 - $111,698
-1,579 Reduced 12.86%
10,702 $684,000
Q1 2023

Apr 14, 2023

BUY
$65.71 - $74.53 $110,589 - $125,433
1,683 Added 15.88%
12,281 $851,000
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $12,120 - $14,352
-177 Reduced 1.64%
10,598 $762,000
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $36 - $21,745
283 Added 2.7%
10,775 $766,000
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $56,207 - $61,904
-774 Reduced 6.87%
10,492 $807,000
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $237,497 - $284,780
-3,863 Reduced 25.53%
11,266 $823,000
Q4 2021

Feb 04, 2022

BUY
$53.63 - $62.52 $811,368 - $945,865
15,129 New
15,129 $944,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Congress Wealth Management LLC Portfolio

Follow Congress Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Congress Wealth Management LLC with notifications on news.